Related Experiment Video
Updated: Jul 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Evaluation and management of severe asthma
Mina Gaga1, Eleftherios Zervas, Spiros Grivas
1Asthma Centre and 7th Respiratory Medicine Department, Sotiria Hospital, Athens, Greece. mgaga@med.uoa.gr
Severe asthma management remains challenging despite guideline therapies. New treatments like anti-IgE antibodies and anti-cytokines show promise for refractory asthma patients.
Area of Science:
- Pulmonology and Respiratory Medicine
- Clinical Immunology
- Pharmacology
Background:
- Severe asthma significantly impacts patient health and healthcare costs.
- Current guideline-based treatments, including high-dose inhaled corticosteroids (ICS) and long-acting beta2-agonists (LABA), often fail in refractory cases.
- Uncertainties persist regarding optimal dosing, steroid-responsiveness, and safety of existing therapies.
Purpose of the Study:
- To review current guideline-based therapies for severe asthma.
- To explore emerging treatment strategies and novel therapeutic targets.
- To address uncertainties in the management of difficult-to-treat asthma.
Main Methods:
- Review of existing literature on severe asthma management.
- Analysis of clinical trial data for novel therapies.
- Discussion of current challenges and future directions in severe asthma treatment.
Main Results:
- Standard treatments often yield unsatisfactory outcomes in severe asthma.
- Biologics such as anti-Immunoglobulin E (IgE) show clinical benefit.
- Anti-cytokine therapies (anti-IL-5, anti-TNFalpha) are under investigation with mixed results.
- Steroid-sparing agents have shown limited efficacy and notable side effects.
- Macrolide addition may be beneficial, potentially linked to chronic infection.
Conclusions:
- Steroids remain central to severe asthma management, but novel approaches are crucial.
- Targeted therapies like anti-IgE and anti-cytokines represent promising avenues.
- Further research is needed to optimize treatment and address management uncertainties in severe asthma.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...